Phesgo 1200mg/600mg (Pertuzumab - Trastuzumab Vials) 1200mg/600mg / 15ml

Phesgo 1200mg/600mg is a combination therapy for HER2-positive breast cancer treatment. This injectable solution combines pertuzumab and trastuzumab in a single vial. Store between 2-8°C to maintain potency. Always follow healthcare provider instructions for use.

Strength

1200mg/600mg / 15ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Roche Pharma Switzerland

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Phesgo 1200mg/600mg is used for treating HER2-positive breast cancer in adults. It combines two monoclonal antibodies that target the HER2 protein to slow cancer cell growth. This medication is typically administered alongside chemotherapy. Patients often ask what is Phesgo used for in cancer treatment.

Side Effects

Phesgo 1200mg/600mg works by binding to HER2 receptors on cancer cells, helping to stop their growth and spread. Common effects include reduced tumor size and slower disease progression. Some patients may experience mild injection site reactions or fatigue during treatment.

Precautions & Warnings

Phesgo 1200mg/600mg requires careful handling and storage at 2-8°C to maintain effectiveness. Always check the solution for particles or discoloration before use. Avoid freezing or shaking the vial. Patients should discuss their full medical history with their healthcare provider before starting this therapy.

Avoid Interactions

Phesgo 1200mg/600mg may interact with other medications that affect the immune system, such as immunosuppressants. Certain chemotherapy drugs or other HER2-targeted therapies may require dose adjustments. Always inform your healthcare provider about all medications you are taking before starting Phesgo.

Frequently Asked Questions

Phesgo 1200mg/600mg is used to treat HER2-positive breast cancer in adults.

Phesgo is given as an injection by a healthcare professional, typically in a clinical setting.

Common effects may include fatigue, injection site reactions, or mild nausea.

Phesgo requires a prescription and should only be obtained through licensed pharmacies or healthcare providers.

Store Phesgo between 2-8°C and protect it from freezing or direct light.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 28 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.